Lv6
2340 积分 2021-11-05 加入
Multidisciplinary expert consensus on diagnosis and treatment of multiple lung cancers
2小时前
待确认
Perioperative Nivolumab in Resectable Lung Cancer
1年前
已完结
Perioperative toripalimab + platinum-doublet chemotherapy vs chemotherapy in resectable stage II/III non-small cell lung cancer (NSCLC): Interim event-free survival (EFS) analysis of the phase III Neotorch study
1年前
已完结
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
1年前
已完结
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
1年前
已完结
Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
1年前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
1年前
已完结
Cancer incidence and mortality in China, 2022
1年前
已完结
Construction of an Anoikis-Related Gene Prognostic Signature and Identification of ANGPTL4 as a Key Oncogene in Lung Adenocarcinoma
1年前
已完结
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
1年前
已完结
皖公网安备34019202002308
